← Leaderboards
John S. Adams
La Biomed Res Inst/ Harbor Ucla Med Ctr
$12,304,676
Attributed
$15,675,351
Total exposure
16
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,675,351 · 16
By mechanism
R01$8,192,060 · 5
T32$4,319,501 · 1
P50$1,712,108 · 1
M01$770,410 · 7
R21$681,272 · 2
Top collaborators
- Karen M. Lyons15 shared
- Nicholas M. Bernthal5 shared
- Martin Hewison5 shared
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Rajnish Mehrotra$10,175,876
- Daniel S Berman$2,014,916
Others in their field
Top investigators on “Vitamin D”
- Anastassios G Pittas · Tufts Medical Center$51,902,200
- John Anthony Baron · Dartmouth College$46,428,739
- Steven R Cummings · University Of California San Francisco$40,078,859
- William J. Blot · Vanderbilt University$36,941,169
- Julie E Buring · Brigham And Women'S Hospital$32,336,058
- David Leung · National Jewish Health$31,859,607
Research focus
Vitamin DPhenotypeHuman SubjectCellsGenesBinding ProteinsSteroid HormoneHormonesClinical ResearchTechnologyLinkMedicineIn VivoVitamin D3 ReceptorRegenerativeMusculoskeletalTraining ProgramsHormone Regulation /Control MechanismResponseResearch StudyTissuesSkeletonSignal PathwayMixed Function Oxygenases
Grant awards (67)
Regenerative Musculoskeletal Medicine Training Program$459,392
T32 · FY2025 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$315,195
T32 · FY2024 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$426,954
T32 · FY2023 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$351,474
T32 · FY2022 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$279,174
T32 · FY2021 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$317,704
T32 · FY2020 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$210,249
T32 · FY2019 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$259,933
T32 · FY2018 · AR · contact PI
DBP and the bioavailability and function of vitamin D$314,981
R01 · FY2017 · AR · contact PI
Impact of ethnicity in the gut microbiome in response to oral vitamin D replacement$301,854
R21 · FY2017 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$239,707
T32 · FY2017 · AR · contact PI
Vitamin D Metabolism in Leprosy$365,423
P50 · FY2016 · AR · contact PI
DBP and the bioavailability and function of vitamin D$314,981
R01 · FY2016 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$268,819
T32 · FY2016 · AR · contact PI
DBP and the bioavailability and function of vitamin D$401,332
R01 · FY2015 · AR · contact PI
Vitamin D Metabolism in Leprosy$365,423
P50 · FY2015 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$246,221
T32 · FY2015 · AR · contact PI
DBP and the bioavailability and function of vitamin D$401,332
R01 · FY2014 · AR · contact PI
Vitamin D Metabolism in Leprosy$332,632
P50 · FY2014 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$219,747
T32 · FY2014 · AR · contact PI
Vitamin D and Estrogen Action in Bone: Concerted Role for hnRNPs in the C Family$392,331
R01 · FY2013 · AR · contact PI
DBP and the bioavailability and function of vitamin D$378,494
R01 · FY2013 · AR
Vitamin D Metabolism in Leprosy$315,998
P50 · FY2013 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$211,687
T32 · FY2013 · AR · contact PI
Vitamin D and Estrogen Action in Bone: Concerted Role for hnRNPs in the C Family$420,107
R01 · FY2012 · AR · contact PI
Vitamin D Metabolism in Leprosy$332,632
P50 · FY2012 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$256,778
T32 · FY2012 · AR · contact PI
Vitamin D and Estrogen Action in Bone: Concerted Role for hnRNPs in the C Family$425,955
R01 · FY2011 · AR · contact PI
Regenerative Musculoskeletal Medicine Training Program$256,467
T32 · FY2011 · AR · contact PI
Vitamin D and Estrogen Action in Bone: Concerted Role for hnRNPs in the C Family$35,406
R01 · FY2011 · AR · contact PI
Vitamin D and Estrogen Action in Bone: Concerted Role for hnRNPs in the C Family$366,380
R01 · FY2010 · AR · contact PI
Orthopaedic Wear Debris, Vitamin D, and Innate Immunity$171,518
R21 · FY2010 · AR · contact PI
EFFECTS OF VITAMIN D INSUFFICIENCY IN MAN$1,978
M01 · FY2010 · RR · contact PI
Vitamin D and Estrogen Action in Bone: Concerted Role for hnRNPs in the C Family$397,868
R01 · FY2009 · AR · contact PI
Orthopaedic Wear Debris, Vitamin D, and Innate Immunity$207,900
R21 · FY2009 · AR · contact PI
VITAMIN D RESISTANCE: MONKEY TO MAN$338,425
R01 · FY2008 · AR · contact PI
VITAMIN D RESISTANCE: MONKEY TO MAN$338,666
R01 · FY2007 · AR · contact PI
VITAMIN D RESISTANCE: MONKEY TO MAN$33,050
R01 · FY2007 · AR · contact PI
VITAMIN D INSUFFICIENCY AS AN INTERVAL CAUSE OF DIMINISHED BONE MINERAL DENSITY$13,680
M01 · FY2007 · RR · contact PI
VITAMIN D RESISTANCE: MONKEY TO MAN$346,560
R01 · FY2006 · AR · contact PI
VITAMIN D RESISTANCE: MONKEY TO MAN$343,622
R01 · FY2005 · AR
Vitamin D and Barrier Function$283,920
R01 · FY2005 · AR
VITAMIN D RESISTANCE: MONKEY TO MAN$354,900
R01 · FY2004 · AR
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM$344,250
R01 · FY2004 · DK
Vitamin D and Barrier Function$274,488
R01 · FY2004 · AR
Genetic Determinants of Osteoporosis Susceptibility$37,872
M01 · FY2004 · RR
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM$344,250
R01 · FY2003 · DK
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM$321,765
R01 · FY2002 · DK
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM$330,960
R01 · FY2001 · DK
RICKETS AND OSTEOMALACIA IN NEW WORLD PRIMATES$261,644
R01 · FY2001 · AR
PHENOTYPIC &GENOTYPIC CHARACTERIZATION OF KINDRED RENAL MAGNESIUM WA$237,978
M01 · FY2001 · RR
INFLUENCE OF CHRONIC DAILY BISPHOSPHONATE THERAPY ON ATHEROMATOUS PLAQUE$237,978
M01 · FY2001 · RR
TREATMENT OF HYPERCALCEMIC/HYPERCALCIURIC PATIENTS W/ CHLOROQUINE,HYD$237,978
M01 · FY2001 · RR
RICKETS AND OSTEOMALACIA IN NEW WORLD PRIMATES$254,426
R01 · FY2000 · AR
BISPHOSPHONATES AND EXTRAOSSEOUS CALCIFICATION$171,967
R01 · FY2000 · AR
PHENOTYPIC &GENOTYPIC CHARACTERIZATION OF KINDRED RENAL MAGNESIUM WA$982
M01 · FY2000 · RR
INFLUENCE OF CHRONIC DAILY BISPHOSPHONATE THERAPY ON ATHEROMATOUS PLAQUE$982
M01 · FY2000 · RR
TREATMENT OF HYPERCALCEMIC/HYPERCALCIURIC PATIENTS W/ CHLOROQUINE,HYD$982
M01 · FY2000 · RR
TREATMENT OF HYPERCALCEMIC/HYPERCALCIURIC PATIENTS W/ CHLOROQUINE,HYD$0
M01 · FY2000 · RR
Vitamin D metabolism in sarcoidosis$0
M01 · FY2000 · RR
Vitamin D metabolism in sarcoidosis$0
M01 · FY2000 · RR
Vitamin D metabolism in sarcoidosis$0
M01 · FY2000 · RR
PHENOTYPIC &GENOTYPIC CHARACTERIZATION OF KINDRED RENAL MAGNESIUM WA$0
M01 · FY2000 · RR
PHENOTYPIC &GENOTYPIC CHARACTERIZATION OF KINDRED RENAL MAGNESIUM WA$0
M01 · FY2000 · RR
INFLUENCE OF CHRONIC DAILY BISPHOSPHONATE THERAPY ON ATHEROMATOUS PLAQUE$0
M01 · FY2000 · RR
INFLUENCE OF CHRONIC DAILY BISPHOSPHONATE THERAPY ON ATHEROMATOUS PLAQUE$0
M01 · FY2000 · RR
TREATMENT OF HYPERCALCEMIC/HYPERCALCIURIC PATIENTS W/ CHLOROQUINE,HYD$0
M01 · FY2000 · RR